We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oxford Biomedica and Sigma to Commercialize Lentivector® Technology

News   Oct 21, 2005

 
Oxford Biomedica and Sigma to Commercialize Lentivector® Technology
 
 
 

RELATED ARTICLES

The "Midlife Crisis" of Molecular Aging

News

Key molecular programs known to promote longevity do not last beyond midlife, according to a study of genomic patterns in human muscle and brain tissue. The study suggests a possible explanation for why the human disease burden increases so sharply from the sixth decade of life.

READ MORE

tRNA a Warning System for Oncoming Epileptic Seizures?

News

Changes in the concentration of specific transfer RNAs, a major class of noncoding RNA, are associated with epilepsy. The findings suggest that tRNA fragments could serve as an early warning system for predicting seizure risk.

READ MORE

Hundreds of Microproteins Detected in the Human Heart

News

Hundreds of previously undetected microproteins have been identified in the human heart. They have been associated with diverse cellular processes and compartments, many of which locate to the mitochondria.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE